"As I recall (no reference) a few years ago on ABC TV bus news the CEO of cocklear stated that mesoblast is the only bio med company (in his opinion) that has the potential to be another CSL. Take out of it what you will but it was one of the insights that re-enforced MSB to my attention now just need to be patient during teething times."
FYI - I don't know who made the quote either but Donal O'Dwyer is a non-executive director of Mesoblast and also on the board of directors of Cochlear.
Next 12 months, page-40
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |